Episode notes
In this Curie episode, Matt previews what’s coming at AACR 2025, happening April 25–30 in Chicago. Get ready for a data-packed week with practice-changing trials like KEYNOTE-689 and Beamion LUNG-1, along with fresh momentum in AI-powered oncology, cancer interception, and new modalities like peptide drug conjugates and RNA-targeting agents. From early detection to trial equity, this preview outlines the trends and themes every oncologist should be watching ahead of the meeting.
Keywords
HER2
Head cancer
Neck cancer
NSCLC
Immunotherapy
AACR
Clinical trials
Early cancer detection
Cancer interception
Predictive oncology
KRAS inhibitors
HER2 mutations
PARP inhibitors
Cancer research